CRMD CorMedix Inc.
CorMedix Inc. (CRMD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $665.1K.
Where they traded
Last open-market purchase: October 23, 2025 , by Kaplan Myron .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Dillione Janet | Director | Sell | 10,000 | $6.88 | $68.8K | 38,473 −20.6% of holding | |
| DUNTON ALAN W | Director | Sell | 20,000 | $13.00 | $260.0K | 40,250 −33.2% of holding | |
| Todisco Joseph | Chief Executive Officer | Sell | 30,000 | $12.00 | $360.0K | 509,496 −5.6% of holding | |
| Lefkowitz Steven W | Director | Sell | 40,000 | $11.88 | $475.2K | 80,498 −33.2% of holding | |
| Dillione Janet | Director | Sell | 34,000 | $12.00 | $408.0K | 48,473 −41.2% of holding | |
| Dillione Janet | Director | Sell | 46,657 | $10.00 | $466.6K | 48,473 −49% of holding | |
| Dillione Janet | Director | Sell | 26,343 | $9.93 | $261.6K | 48,473 −35.2% of holding | |
| Dillione Janet | Director | Sell | 30,000 | $11.42 | $342.6K | 48,473 −38.2% of holding | |
| Kaplan Myron | Director | Buy | 25,000 | $11.02 | $275.5K | 201,034 | |
| Todisco Joseph | Chief Executive Officer | Sell | 50,000 | $13.00 | $650.0K | 509,496 −8.9% of holding | |
| DUNTON ALAN W | Director | Sell | 10,000 | $13.13 | $131.3K | 40,250 −19.9% of holding | |
| Hurlburt Elizabeth | Chief Operating Officer | Sell | 41,121 | $13.08 | $537.9K | 176,990 −18.9% of holding | |
| Zelnick Kaufman Beth 2 fills | Chief Legal Officer | Sell | 50,000 | $13.41 | $670.3K | 180,818 −21.7% of holding | |
| Hurlburt Elizabeth | Chief Operating Officer | Sell | 12,876 | $13.51 | $174.0K | 176,990 −6.8% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.